Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic

Explore clinical trials studying Anemia, Hemolytic. Study availability and eligibility vary by location and protocol.

1,383 public trials 241 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic trial results

Recruiting

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

NCT06481306

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego - La Jolla La Jolla, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 33 locations
View Trial Details
Recruiting

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

NCT04819841

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Washington University St Louis, Missouri, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

NCT01174108

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +11 more
Locations
  • University of Maryland, Baltimore (UMB) Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

NCT04064060

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations
  • Local Institution - 968 Los Angeles, California, United States
  • Local Institution - 971 Oakland, California, United States
  • Local Institution - 978 Stanford, California, United States
  • Local Institution - 975 Tampa, Florida, United States
View all 143 locations
View Trial Details
Recruiting

A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT05776472

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Canberra Hospital Garran, Australia
View all 87 locations
View Trial Details
Recruiting

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07229235

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Alessandria, AL, Italy
  • Novartis Investigative Site Avellino, AV, Italy
  • Novartis Investigative Site Brescia, BS, Italy
  • Novartis Investigative Site Florence, FI, Italy
View Trial Details
Recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT05664737

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Local Institution - 0008 Halifax, Nova Scotia, Canada
  • Sun Yat-sen Memorial Hospital, Sun Yat-Sen University Guangzhou, GD, China
  • Nanfang Hospital of Southern Medical University Guangzhou, GD, China
  • The First People's Hospital of Foshan Foshan, Guangdong, China
View all 36 locations
View Trial Details

Related conditions